Cellanyx Diagnostics was recognized by the Boston Business Journal for winning the Massachusetts Medical Device Development Center (M2D2) New Venture Competition, receiving $5,o00 worth of credit. The business plans to use these funds for engineering, facilities services and product development
According to Ashok Chander the CEO of Cellanyx, the company was also honored by Boston University and received $20,000 from Cummings and $50,000 dollars from Wilmer Hale.
“In the coming years we will continue to accrue clinical data for prostate cancer diagnostics as well as work on product development,” said Chander.
http://www.bizjournals.com/boston/blog/bioflash/2013/04/trio-of-med-device-startups-named-m2d2.html
Leave a Comment